Clinical application study of platelet-rich plasma (PRP) in the treatment of small rotator cuff tears

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040143

Enrollment

Unknown

Registered

2020-11-22

Start date

2020-11-18

Completion date

Unknown

Last updated

2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tear

Interventions

Treatment group and control group:PRP injection

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of rotator cuff injury and diagnosed as small rotator cuff tendon injury by magnetic resonance imaging (MRI) (tear range <1cm); 2. within 6 months of onset; 3. voluntarily sign an informed consent; 4. aged 40 to 80 years old; 5. Stable vital signs.

Exclusion criteria

Exclusion criteria: 1. Severe infection of the shoulder joint; 2. Shoulder joint tumor, gout or other inflammatory diseases; 3. Severe liver and kidney dysfunction; 4. Severe illness such as coma with severe complications; 5. Uncontrolled High blood pressure or severe cardiovascular and cerebrovascular diseases.

Design outcomes

Primary

Measure	Time frame
UCLA functional scoring standard for shoulder joint;	—

Countries

China

Contacts

Public ContactPeng Liang-Quan

Shenzhen Second People's Hospital

szplq@126.com+86 13760350192

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026